These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 19912506)
1. The relationship of testosterone to prostate-specific antigen in men with sexual dysfunction. Corona G; Boddi V; Lotti F; Gacci M; Carini M; De Vita G; Sforza A; Forti G; Mannucci E; Maggi M J Sex Med; 2010 Jan; 7(1 Pt 1):284-92. PubMed ID: 19912506 [TBL] [Abstract][Full Text] [Related]
2. Serum PSA as a predictor of testosterone deficiency. Rastrelli G; Corona G; Vignozzi L; Maseroli E; Silverii A; Monami M; Mannucci E; Forti G; Maggi M J Sex Med; 2013 Oct; 10(10):2518-28. PubMed ID: 23859334 [TBL] [Abstract][Full Text] [Related]
3. ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction. Corona G; Mannucci E; Petrone L; Balercia G; Fisher AD; Chiarini V; Forti G; Maggi M J Sex Med; 2006 Jul; 3(4):706-715. PubMed ID: 16839327 [TBL] [Abstract][Full Text] [Related]
4. Different testosterone levels are associated with ejaculatory dysfunction. Corona G; Jannini EA; Mannucci E; Fisher AD; Lotti F; Petrone L; Balercia G; Bandini E; Chiarini V; Forti G; Maggi M J Sex Med; 2008 Aug; 5(8):1991-8. PubMed ID: 18399946 [TBL] [Abstract][Full Text] [Related]
5. Hysterical traits are not from the uterus but from the testis: a study in men with sexual dysfunction. Bandini E; Corona G; Ricca V; Fisher AD; Lotti F; Sforza A; Faravelli C; Forti G; Mannucci E; Maggi M J Sex Med; 2009 Aug; 6(8):2321-31. PubMed ID: 19493294 [TBL] [Abstract][Full Text] [Related]
6. The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction. Corona G; Boddi V; Balercia G; Rastrelli G; De Vita G; Sforza A; Forti G; Mannucci E; Maggi M J Sex Med; 2010 Apr; 7(4 Pt 1):1547-56. PubMed ID: 20141585 [TBL] [Abstract][Full Text] [Related]
7. Prostatic specific antigen in patients with hypogonadism: effect of testosterone replacement. El-Sakka AI; Hassoba HM; Elbakry AM; Hassan HA J Sex Med; 2005 Mar; 2(2):235-40. PubMed ID: 16422891 [TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment. Raynaud JP; Gardette J; Rollet J; Legros JJ BJU Int; 2013 May; 111(6):880-90. PubMed ID: 23294726 [TBL] [Abstract][Full Text] [Related]
9. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone. Reyes-Vallejo L; Lazarou S; Morgentaler A J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806 [TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement. Gerstenbluth RE; Maniam PN; Corty EW; Seftel AD J Androl; 2002; 23(6):922-6. PubMed ID: 12399540 [TBL] [Abstract][Full Text] [Related]
11. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study). Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A; Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040 [TBL] [Abstract][Full Text] [Related]
12. The relationship between testosterone and sexual function in depressed and healthy men. Rizvi SJ; Kennedy SH; Ravindran LN; Giacobbe P; Eisfeld BS; Mancini D; McIntyre RS J Sex Med; 2010 Feb; 7(2 Pt 1):816-25. PubMed ID: 19796059 [TBL] [Abstract][Full Text] [Related]
13. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Corona G; Mannucci E; Schulman C; Petrone L; Mansani R; Cilotti A; Balercia G; Chiarini V; Forti G; Maggi M Eur Urol; 2006 Sep; 50(3):595-604; discussion 604. PubMed ID: 16564129 [TBL] [Abstract][Full Text] [Related]
14. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy. Rhoden EL; Morgentaler A Int J Impot Res; 2006; 18(2):201-5. PubMed ID: 16177827 [TBL] [Abstract][Full Text] [Related]
15. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy. Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272 [TBL] [Abstract][Full Text] [Related]
16. Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism. Corona G; Mannucci E; Lotti F; Boddi V; Jannini EA; Fisher AD; Monami M; Sforza A; Forti G; Maggi M J Sex Med; 2009 Sep; 6(9):2591-600. PubMed ID: 19515208 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less. Morgentaler A; Rhoden EL Urology; 2006 Dec; 68(6):1263-7. PubMed ID: 17169647 [TBL] [Abstract][Full Text] [Related]
18. The effect of parenteral testosterone replacement on prostate specific antigen in hypogonadal men with erectile dysfunction. Svetec DA; Canby ED; Thompson IM; Sabanegh ES J Urol; 1997 Nov; 158(5):1775-7. PubMed ID: 9334599 [TBL] [Abstract][Full Text] [Related]
19. Factors influencing prostate-specific antigen response among men treated with testosterone therapy for 6 months. Morgentaler A; Benesh JA; Denes BS; Kan-Dobrosky N; Harb D; Miller MG J Sex Med; 2014 Nov; 11(11):2818-25. PubMed ID: 25131184 [TBL] [Abstract][Full Text] [Related]
20. The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction. Corona G; Mannucci E; Ricca V; Lotti F; Boddi V; Bandini E; Balercia G; Forti G; Maggi M Int J Androl; 2009 Dec; 32(6):720-8. PubMed ID: 19226406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]